Audrey M Hamilton MD

PubMed

• 8 citations
  TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.
  William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson, Alison J Moskowitz, Robert N Stuver
  Blood Advances. 2023-09-12
• 71 citations
  Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
  Robert Stuver, Gunjan L Shah, Neha S Korde, Lindsey E Roeker, Anthony R Mato
  Cancer Cell. 2022-06-13
• 2 citations
  Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
  Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi
  Blood Cancer Journal. 2022-02-10

Abstracts/Posters

• High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed ...
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Retrospective Analysis of Gemcitabine and Oxaliplatin (GemOx)-Based Treatment in Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma
  Audrey Hamilton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all